IDH1 and cancer: For cancers with a non-stem cell origin including liver, breast, lung, pancreatic, and prostate cancers, in which mutations on metabolic genes are not widespread, Goding et al. (7) propose that an intact metabolic function of IDH would be necessary to maintain DNA methylation plasticity and a flexible epigenetic landscape, as seen during the generation of iPSCs.